Twin Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,342	Closed	-$3.33M	–	313
2020 Q4	$3.33M	Sell	21,342 -1,500	-7%	-$193K	0.3%	103
2020 Q3	$2.61M	Sell	22,842 -1,145	-5%	-$124K	0.24%	123
2020 Q2	$2.69M	Sell	23,987 -1,949	-8%	-$207K	0.26%	122
2020 Q1	$2.33M	Buy	25,936 +1,110	+4%	+$109K	0.25%	125
2019 Q4	$2.69M	Sell	24,826 -4,810	-16%	-$514K	0.23%	139
2019 Q3	$2.9M	Sell	29,636 -1,564	-5%	-$176K	0.21%	148
2019 Q2	$4.09M	Sell	31,200 -15,970	-34%	-$2.06M	0.28%	121
2019 Q1	$6.38M	Buy	47,170 +80	+0.2%	+$9.95K	0.31%	99
2018 Q4	$4.58M	Buy	47,090 +41,708	+775%	+$4.93M	0.26%	120
2018 Q3	$748K	Buy	+5,382	New	+$675K	0.03%	286
2018 Q2	–	Sell	-8,375	Closed	-$933K	–	368
2018 Q1	$933K	Sell	8,375 -30,411	-78%	-$3.63M	0.05%	277
2017 Q4	$4.64M	Buy	38,786 +8,136	+27%	+$991K	0.23%	127
2017 Q3	$4.3M	Buy	30,650 +4,640	+18%	+$630K	0.23%	129
2017 Q2	$3.17M	Buy	26,010 +2,090	+9%	+$243K	0.19%	166
2017 Q1	$2.9M	Sell	23,920 -180	-0.7%	-$23.2K	0.18%	174
2016 Q4	$2.95M	Buy	24,100 +320	+1%	+$39.2K	0.19%	162
2016 Q3	$2.91M	Buy	23,780 +5,390	+29%	+$694K	0.2%	161
2016 Q2	$2.15M	Sell	18,390 -1,600	-8%	-$227K	0.16%	163
2016 Q1	$2.78M	Buy	19,990 +680	+4%	+$99.8K	0.22%	139
2015 Q4	$3.68M	Buy	19,310 +2,550	+15%	+$445K	0.3%	100
2015 Q3	$2.62M	Buy	16,760 +470	+3%	+$85.7K	0.25%	127
2015 Q2	$2.94M	Sell	16,290 -5,420	-25%	-$935K	0.26%	122
2015 Q1	$3.76M	Buy	21,710 +2,270	+12%	+$411K	0.33%	97
2014 Q4	$3.6M	Buy	19,440 +5,960	+44%	+$1.1M	0.34%	90
2014 Q3	$2.23M	Buy	+13,480	New	+$2.21M	0.23%	135